News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
90,509 Results
Type
Article (6319)
Company Profile (265)
Press Release (83925)
Multimedia
Podcasts (99)
Webinars (5)
Section
Business (29385)
Career Advice (141)
Deals (4835)
Drug Delivery (36)
Drug Development (11600)
Employer Resources (19)
FDA (1976)
Job Trends (2173)
News (43171)
Policy (3209)
Tag
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Standard (1)
Academia (292)
Accelerated approval (10)
ADA (3)
Adcomms (6)
Allergies (36)
Alliances (3414)
ALS (41)
Alzheimer's disease (272)
Antibody-drug conjugate (ADC) (137)
Approvals (2160)
Artificial intelligence (140)
ASCO (58)
Autoimmune disease (69)
Automation (8)
Bankruptcy (49)
Belgium (3)
Best Places to Work (1861)
BIO (10)
BIOSECURE Act (8)
Biosimilars (51)
BioSpace Insights (44)
Biotechnology (112)
Bladder cancer (62)
Brain cancer (18)
Breast cancer (170)
Cancer (1445)
Cardiovascular disease (155)
Career advice (141)
Career pathing (4)
CAR-T (78)
CDC (13)
CDMO (69)
Cell therapy (217)
Cervical cancer (17)
Clinical research (11188)
Collaboration (389)
Commercialization (4)
Company closure (6)
Compensation (177)
Complete response letters (21)
COVID-19 (507)
CRISPR (25)
C-suite (166)
Cystic fibrosis (31)
Data (2008)
Decentralized trials (1)
Denatured (23)
Depression (52)
Dermatology (48)
Diabetes (137)
Diagnostics (1026)
Digital health (13)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (70)
Drug pricing (85)
Drug shortages (14)
Duchenne muscular dystrophy (93)
Earnings (21156)
Editorial (32)
Employer branding (4)
Employer resources (21)
Events (15377)
Executive appointments (118)
FDA (2915)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (4)
Frontotemporal dementia (3)
Funding (343)
Gene editing (68)
Generative AI (16)
Gene therapy (205)
GLP-1 (328)
Government (632)
Grass and pollen (1)
Guidances (208)
Healthcare (2715)
Hematology (26)
HIV (22)
Huntington's disease (15)
IgA nephropathy (23)
Immunology and inflammation (141)
Immuno-oncology (36)
Indications (48)
Infectious disease (595)
Inflammatory bowel disease (35)
Inflation Reduction Act (4)
Influenza (23)
Intellectual property (35)
Interviews (22)
IPO (2905)
IRA (12)
Job creations (408)
Job search strategy (106)
JPM (46)
Kidney cancer (2)
Labor market (34)
Layoffs (182)
Leadership (15)
Legal (519)
Licensing (3)
Liver cancer (31)
Longevity (5)
Lung cancer (181)
Lymphoma (93)
Machine learning (11)
Management (4)
Manufacturing (301)
Marketing (3)
MASH (58)
Medical affairs (1)
Medical device (2114)
Medtech (2147)
Mergers & acquisitions (2273)
Metabolic disorders (502)
mRNA (79)
Multiple sclerosis (46)
NASH (6)
Netherlands (2)
Neurodegenerative disease (98)
Neuropsychiatric disorders (43)
Neuroscience (630)
NextGen: Class of 2026 (847)
Non-profit (563)
Now hiring (8)
Obesity (296)
Opinion (64)
Ovarian cancer (46)
Pain (42)
Pancreatic cancer (95)
Parkinson's disease (78)
Partnered (14)
Patents (86)
Patient recruitment (129)
Peanut (7)
People (2799)
Pharmaceutical (24)
Pharmacy benefit managers (12)
Phase 1 (2804)
Phase 2 (4707)
Phase 3 (4591)
Pipeline (2902)
Policy (120)
Postmarket research (413)
Preclinical (851)
Press Release (18)
Prostate cancer (67)
Psychedelics (23)
Radiopharmaceuticals (75)
Rare diseases (330)
Real estate (492)
Recruiting (13)
Regulatory (3275)
Reports (13)
Research institute (287)
Resumes & cover letters (13)
Rett syndrome (12)
RNA editing (10)
RSV (33)
Schizophrenia (41)
Series A (56)
Series B (46)
Service/supplier (4)
Sickle cell disease (26)
Special edition (10)
Spinal muscular atrophy (44)
Sponsored (8)
Startups (378)
Stomach cancer (5)
Supply chain (48)
Tariffs (65)
The Weekly (74)
Vaccines (286)
Venture capital (105)
Weight loss (214)
Women's health (21)
Date
Today (17)
Last 7 days (117)
Last 30 days (468)
Last 365 days (6347)
2026 (4357)
2025 (6456)
2024 (6984)
2023 (5839)
2022 (8165)
2021 (9828)
2020 (8478)
2019 (5459)
2018 (4905)
2017 (3576)
2016 (3279)
2015 (3884)
2014 (2547)
2013 (1778)
2012 (2074)
2011 (2279)
2010 (1902)
Location
Africa (91)
Alabama (15)
Arizona (52)
Arkansas (3)
Asia (4979)
Australia (688)
California (2994)
Canada (753)
China (353)
Colorado (179)
Connecticut (159)
Delaware (96)
Europe (12356)
Florida (355)
Georgia (106)
Idaho (7)
Illinois (209)
India (18)
Indiana (253)
Iowa (1)
Japan (170)
Kansas (48)
Kentucky (13)
Louisiana (19)
Maine (14)
Maryland (297)
Massachusetts (2222)
Michigan (70)
Minnesota (146)
Mississippi (3)
Missouri (39)
Montana (2)
Nebraska (4)
Nevada (18)
New Hampshire (16)
New Jersey (923)
New Mexico (4)
New York (776)
North Carolina (383)
Northern California (1596)
Ohio (76)
Oregon (2)
Pennsylvania (642)
Puerto Rico (5)
Rhode Island (6)
South America (129)
South Carolina (9)
Southern California (1164)
Tennessee (41)
Texas (437)
United States (10682)
Utah (67)
Vermont (1)
Virginia (49)
Washington D.C. (20)
Washington State (262)
West Virginia (2)
Wisconsin (25)
90,509 Results for "90".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
August biopharma layoffs impact just over 500, down 90% year over year
Last month, biotech and pharma companies making or planning workforce cuts included three whose reductions will more than halve their workforces. Blueprint Medicines’ layoffs will affect the most employees.
September 10, 2026
·
6 min read
·
Angela Gabriel
Press Releases
Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering
April 20, 2026
·
5 min read
Press Releases
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
August 9, 2026
·
8 min read
Press Releases
Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit
August 27, 2026
·
5 min read
Press Releases
Sirtex Medical’s DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC
April 14, 2026
·
3 min read
Press Releases
Epicrispr Biotechnologies Closes $90 Million Oversubscribed Series C Financing to Advance First-in-Class Epigenetic Therapy Toward Pivotal Studies in FSHD
August 11, 2026
·
4 min read
Press Releases
Channel Methods Launches MethodsSignals for Life Sciences Business Development
Formulated Solutions reports a more than 90% reduction in time from market insight to customer outreach.
August 26, 2026
·
1 min read
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
·
6 min read
Press Releases
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 30, 2026
·
5 min read
Press Releases
Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models
August 6, 2026
·
5 min read
1 of 9,051
Next
